We serve Chemical Name:5-isoxazol-3-ylthiophene-2-sulfonyl chloride CAS:160233-27-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-isoxazol-3-ylthiophene-2-sulfonyl chloride
CAS.NO:160233-27-2
Synonyms:chloro(5-isoxazol-3-yl(2-thienyl))sulfone;5-(Isoxazol-3-yl)thiophene-2-sulfonyl chloride
Molecular Formula:C7H4ClNO3S2
Molecular Weight:249.69500
HS Code:2934999090
Physical and Chemical Properties:
Melting point:77-78ºC
Boiling point:432.9ºC at 760 mmHg
Density:1.591g/cm3
Index of Refraction:1.598
PSA:96.79000
Exact Mass:248.93200
LogP:3.41140
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3261
Packing Group:
Contact us for information like chloro(5-isoxazol-3-yl(2-thienyl))sulfone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(Isoxazol-3-yl)thiophene-2-sulfonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,chloro(5-isoxazol-3-yl(2-thienyl))sulfone Use and application,5-(Isoxazol-3-yl)thiophene-2-sulfonyl chloride technical grade,usp/ep/jp grade.
Related News: A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. 5-isoxazol-3-ylthiophene-2-sulfonyl chloride manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 5-isoxazol-3-ylthiophene-2-sulfonyl chloride supplier Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. 5-isoxazol-3-ylthiophene-2-sulfonyl chloride vendor Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 5-isoxazol-3-ylthiophene-2-sulfonyl chloride factory The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population.
